1) Doxifluridine
5'-脱氧-5-氟尿嘧啶核苷
2) 5-FuDR
5-氟尿嘧啶脱氧核苷
1.
Objective To evaluate the anti-tumor efficacy and safety of intraarterial 5-FuDR infusion and intravenous administration of folinic acid plus 5-fluorouracil in the treatment of colorectal cancer metastasized to liver.
目的 观察肝动脉灌注5-氟尿嘧啶脱氧核苷(5-FuDR)联合全身化疗(CF+5-Fu)治疗不能手术切除大肠癌来源的肝转移瘤患者的疗效和毒性。
3) 5'-dioctanoyl-5-fluoro-2'-deoxyuridine
5'-二辛酰基-5-氟尿嘧啶脱氧核苷
5) BrdU
5-溴脱氧尿嘧啶核苷
1.
Technical explore on mesenchymal stem cells in bone marrow using BrdU labelling;
5-溴脱氧尿嘧啶核苷标记骨髓间充质干细胞的技术探讨
2.
Objective To study the feasibility of labeling adipose-derived adult stem cells with BrdU.
目的探讨5-溴脱氧尿嘧啶核苷(BrdU)标记脂肪成体干细胞(adipose-derived adult stem cells,ADASCs)的可行性。
3.
AIM: To study the differentiation characteristics and the optimal dosage and timing for bromodeoxyuridine (Brdu) labeling of rat bone marrow-derived mesenchymal stem cells (MSCs) in vitro.
目的:探讨骨髓间充质干细胞(MSCs)在体外的诱导分化及5-溴脱氧尿嘧啶核苷(Brdu)标记MSCs的可行性。
6) bromodeoxyuridine
['brəuməudi,ɔksi'juəridi:n]
5-溴脱氧尿嘧啶核苷
1.
To explore the best time and best dose for labeling the MSCs with bromodeoxyuridine(BrdU)in vitro,so as to attain the best tracing guide line of applying MSCs to future research.
目的 建立成人骨髓间充质干细胞(MSCs)体外分离培养和鉴定的方法,探讨连续培养的骨髓间充质干细胞应用5-溴脱氧尿嘧啶核苷(BrdU)标记的稳定性、最佳时间和剂量,争取确定应用骨髓间充质干细胞进行研究最好的示踪指标。
补充资料：5'-脱氧-5-氟尿嘧啶核苷
分子式：C9H11FN2O5
分子量：暂无
CAS号：3094-09-5
性质：暂无
制备方法：暂无
用途：医药中间体。
分子量：暂无
CAS号：3094-09-5
性质：暂无
制备方法：暂无
用途：医药中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条